NM_000553.6:c.513C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000553.6(WRN):​c.513C>T​(p.Cys171Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.708 in 1,612,846 control chromosomes in the GnomAD database, including 407,280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.67 ( 35116 hom., cov: 31)
Exomes 𝑓: 0.71 ( 372164 hom. )

Consequence

WRN
NM_000553.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.75

Publications

32 publications found
Variant links:
Genes affected
WRN (HGNC:12791): (WRN RecQ like helicase) This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]
WRN Gene-Disease associations (from GenCC):
  • Werner syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • osteosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 8-31067041-C-T is Benign according to our data. Variant chr8-31067041-C-T is described in ClinVar as Benign. ClinVar VariationId is 130763.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.75 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.843 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000553.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WRN
NM_000553.6
MANE Select
c.513C>Tp.Cys171Cys
synonymous
Exon 6 of 35NP_000544.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
WRN
ENST00000298139.7
TSL:1 MANE Select
c.513C>Tp.Cys171Cys
synonymous
Exon 6 of 35ENSP00000298139.5
WRN
ENST00000650667.1
n.*127C>T
non_coding_transcript_exon
Exon 5 of 34ENSP00000498593.1
WRN
ENST00000650667.1
n.*127C>T
3_prime_UTR
Exon 5 of 34ENSP00000498593.1

Frequencies

GnomAD3 genomes
AF:
0.673
AC:
102130
AN:
151854
Hom.:
35092
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.530
Gnomad AMI
AF:
0.757
Gnomad AMR
AF:
0.758
Gnomad ASJ
AF:
0.738
Gnomad EAS
AF:
0.864
Gnomad SAS
AF:
0.661
Gnomad FIN
AF:
0.755
Gnomad MID
AF:
0.696
Gnomad NFE
AF:
0.709
Gnomad OTH
AF:
0.666
GnomAD2 exomes
AF:
0.713
AC:
178921
AN:
251004
AF XY:
0.711
show subpopulations
Gnomad AFR exome
AF:
0.528
Gnomad AMR exome
AF:
0.768
Gnomad ASJ exome
AF:
0.740
Gnomad EAS exome
AF:
0.865
Gnomad FIN exome
AF:
0.747
Gnomad NFE exome
AF:
0.704
Gnomad OTH exome
AF:
0.709
GnomAD4 exome
AF:
0.712
AC:
1040462
AN:
1460874
Hom.:
372164
Cov.:
53
AF XY:
0.711
AC XY:
516406
AN XY:
726766
show subpopulations
African (AFR)
AF:
0.526
AC:
17598
AN:
33446
American (AMR)
AF:
0.763
AC:
34099
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.736
AC:
19224
AN:
26116
East Asian (EAS)
AF:
0.875
AC:
34684
AN:
39632
South Asian (SAS)
AF:
0.660
AC:
56908
AN:
86230
European-Finnish (FIN)
AF:
0.739
AC:
39324
AN:
53208
Middle Eastern (MID)
AF:
0.661
AC:
3811
AN:
5764
European-Non Finnish (NFE)
AF:
0.713
AC:
792286
AN:
1111400
Other (OTH)
AF:
0.705
AC:
42528
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
15786
31572
47357
63143
78929
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19876
39752
59628
79504
99380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.672
AC:
102199
AN:
151972
Hom.:
35116
Cov.:
31
AF XY:
0.678
AC XY:
50329
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.530
AC:
21940
AN:
41392
American (AMR)
AF:
0.758
AC:
11574
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.738
AC:
2563
AN:
3472
East Asian (EAS)
AF:
0.864
AC:
4469
AN:
5170
South Asian (SAS)
AF:
0.660
AC:
3181
AN:
4822
European-Finnish (FIN)
AF:
0.755
AC:
7963
AN:
10554
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.709
AC:
48202
AN:
67968
Other (OTH)
AF:
0.668
AC:
1413
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1613
3226
4838
6451
8064
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.691
Hom.:
32303
Bravo
AF:
0.670
Asia WGS
AF:
0.764
AC:
2657
AN:
3478
EpiCase
AF:
0.701
EpiControl
AF:
0.703

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Feb 21, 2014
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Werner syndrome Benign:4
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 24, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Wiskott-Aldrich syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.3
DANN
Benign
0.43
PhyloP100
1.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800389; hg19: chr8-30924557; COSMIC: COSV108141453; API